Recognition and management of adverse cutaneous reactions in patients on enfortumab vedotin and pembrolizumab in the inpatient setting

Bibliographic Details
Published in:	JAAD Case Reports
Main Authors:	Emma L. Myers, BA, Jessica Liu, BA, Sabrina M. Shearer, MD, Sarah A. Myers, MD, Michelle Schneider, MB, BCh, BAO, Christopher Hoimes, DO, Melodi Javid Whitley, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2025-04-01
Subjects:	enfortumab immune checkpoint inhibitor immunotherapy oncodermatology pembrolizumab severe cutaneous adverse reaction
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512625000190

Internet